Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Ligand Pharmaceuticals' Shares Outstanding (Diluted) came in at 21.84 million for Q2 2026, up 9.6% from 19.93 million a year earlier and up 9.8% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Ligand Pharmaceuticals' Shares Outstanding (Diluted) was 20.29 million, up 11.0% from FY2024.

  • Shares Outstanding (Diluted) has increased in each of the last three years, with a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Diluted) was 18.29 million in FY2024 (+3.0%), 17.76 million in FY2023 (+5.3%), 16.87 million in FY2022 (-2.2%) and 17.25 million in FY2021 (+6.6%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) since Q4 2018.
  • Year-over-year, Shares Outstanding (Diluted) has increased for 14 consecutive quarters, with growth averaging 7.7% over the last eight quarters.
  • The fastest year-over-year change in Shares Outstanding (Diluted) over five years came in Q3 2025 (growth of 12.0%), and the weakest in Q1 2022 (a decline of 2.5%).
  • Business Quant data shows LGND's Shares Outstanding (Diluted) at 19.88 million (Q1 2026), 20.29 million (Q4 2025) and 20.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.44 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.77 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.56 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.24 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 5.70 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 21.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.84 Mn
Mar 31, 2026 19.88 Mn
Dec 31, 2025 20.29 Mn
Sep 30, 2025 20.63 Mn
Jun 30, 2025 19.93 Mn
Mar 31, 2025 19.19 Mn
Dec 31, 2024 18.29 Mn
Sep 30, 2024 18.42 Mn
Jun 30, 2024 18.03 Mn
Mar 31, 2024 18.12 Mn
Dec 31, 2023 17.76 Mn
Sep 30, 2023 17.38 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 17.97 Mn
Dec 31, 2022 16.87 Mn
Sep 30, 2022 17.13 Mn
Jun 30, 2022 16.87 Mn
Mar 31, 2022 16.82 Mn
Dec 31, 2021 17.25 Mn
Sep 30, 2021 17.14 Mn
API Access

Ligand Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LGND&period=max&api_key=YOUR_API_KEY